You searched for "IOL"
CAT-QoL questionnaire
The purpose of this study was to use Rasch analysis to inform the refinement of the CAT-QoL amblyopia treatment questionnaire. Of the 342 subjects that were recruited across nine centres, 315 had sufficient clinical data for analysis with RUMM software....
IVTA use in Behçet’s disease
This study aimed to evaluate the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) injection (4mg/0.1ml) in controlling posterior segment inflammation in patients with Behçet’s disease. Medical records of consecutive patients diagnosed with Behçet’s who underwent IVTA between July 2005...
Ocular hypertension following intravitreal steroid injections: a comparative study between triamcinolone-acetonide and dexamethasone-implant
This was a retrospective observational study of steroid response following 1549 intravitreal steroid (TA and Dex) injections. One thousand and seventy-five eyes of 897 patients were reviewed. Glaucoma patients, glaucoma suspects, uveitis, trauma, and cases with less than one month...Spectrum: Ophtec Artisan Aphakia Training Couse
23rd October 9:30am - 12:30pm or 2:30pm to 5:30pm 24th October 10:00am - 2:30 Artisan Aphakia Training Dry Lab Iris Fixation technique with artificial eyes Overview of the wider Ophtec portfolio of premium refractive IOLs and CTRDiscussion / Certification Open...PREVIEW: UKISCRS Cornea & Cataract Day
Taking place on Monday 19 May at The Hilton Liverpool (L1 8LW), just a stone's throw away from 2025's RCOphth Annual Congress, you will be able to find the wonderful team from UKISCRS hosting their Cornea & Cataract Day. Our...Biotech Healthcare unveils Optiflex XTENSE Comfort Plus at ESCRS 2025 (Copenhagen), marking a new era in Full Visual Range EDOF IOLs
Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation...All eyes on the future symposium hailed a great success
Leading providers in the eye healthcare sector, Optegra Eye Health Care and ZEISS, have successfully hosted their annual CPD-accredited symposium, ‘All Eyes on the Future’, bringing together experts from across the ophthalmic sector. The symposium welcomed 90 attendees, including optometrists,...
Eye Healthcare: 90 Years of Progress
Eye Healthcare: 90 Years of Progress by Patrick Condon is far more than a historical account, it is a deeply personal, thoughtful and richly illustrated journey through the most transformative decades in ophthalmology, told by one of Ireland’s most respected...
Micropulse vs. continuous wave trans scleral diode cyclophotocoagulation in refractory glaucoma
Continuous wave cyclophotocoagulation (CWCPC) delivers continuous high intensity energy to the ciliary body in an attempt to reduce aqueous secretion and hence lower IOP. It is often used as a treatment of last resort due to the potential side-effects of...
